Riqicef-T Kid Injection

Description

Ceftriaxone & Tazobactam for Injection

Riqicef-T Kid Injection is a sterile combination of Ceftriaxone and Tazobactam formulated for intravenous (I.V.) and intramuscular (I.M.) administration in pediatric patients. Ceftriaxone is a third-generation cephalosporin antibiotic that provides broad-spectrum antibacterial activity by inhibiting bacterial cell wall synthesis. Tazobactam is a beta-lactamase inhibitor that protects Ceftriaxone from enzymatic degradation, thereby enhancing its effectiveness against beta-lactamase-producing bacteria.

This combination is indicated for the treatment of a wide range of susceptible bacterial infections in children, including infections of the respiratory tract, urinary tract, ear, nose and throat, skin and soft tissues, bones, joints, abdomen, and bloodstream. The addition of Tazobactam extends the antibacterial spectrum and helps overcome bacterial resistance caused by beta-lactamase-producing organisms. Riqicef-T Kid Injection should be administered only under the supervision of a qualified healthcare professional.

Key Benefits

• Broad-spectrum antibacterial activity against susceptible bacteria.
• Enhanced efficacy against beta-lactamase-producing organisms.
• Helps manage moderate to severe bacterial infections in pediatric patients.
• Suitable for both intravenous and intramuscular administration.
• Sterile injectable formulation for rapid systemic action.
• Supports effective treatment of respiratory, urinary, skin, soft tissue, and intra-abdominal infections.
• Intended for use under medical supervision.

Composition

Each vial contains:

• Ceftriaxone IP equivalent to 250 mg
• Tazobactam Sodium IP equivalent to 31.25 mg

Total Strength: 281.25 mg

Indications

Recommended for the treatment of susceptible bacterial infections, including:

• Respiratory tract infections
• Ear, nose and throat infections
• Urinary tract infections
• Skin and soft tissue infections
• Bone and joint infections
• Intra-abdominal infections
• Bloodstream infections (Septicemia)
• Other susceptible bacterial infections as determined by the treating physician

Directions for Use

Reconstitute the vial with the recommended sterile diluent before administration. Administer only by I.V. or I.M. injection under the supervision of a qualified healthcare professional. The dosage and duration of therapy should be determined by the physician based on the patient’s age, body weight, severity of infection, and clinical condition.

Storage

• Store below 25°C in a cool and dry place.
• Protect from light and moisture.
• Use the reconstituted solution within the recommended time.
• Keep out of reach of children.